Literature DB >> 26618994

Exclusion of Patients With Kidney Disease From Cardiovascular Trials.

Julie H Ishida1, Kirsten L Johansen1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26618994      PMCID： PMC4701578          DOI： 10.1001/jamainternmed.2015.6403

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  5 in total

Review 1.  Representation of Patients With Kidney Disease in Trials of Cardiovascular Interventions: An Updated Systematic Review.

Authors:  Ioannis Konstantinidis; Girish N Nadkarni; Rabi Yacoub; Aparna Saha; Priya Simoes; Chirag R Parikh; Steven G Coca
Journal:  JAMA Intern Med       Date:  2016-01       Impact factor: 21.873

Review 2.  Cardiovascular pathophysiology in chronic kidney disease: opportunities to transition from disease to health.

Authors:  Matthew I Tomey; Jonathan A Winston
Journal:  Ann Glob Health       Date:  2013-12-25       Impact factor: 2.462

3.  The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease.

Authors:  D Charytan; R E Kuntz
Journal:  Kidney Int       Date:  2006-10-18       Impact factor: 10.612

Review 4.  Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease.

Authors:  Steven G Coca; Harlan M Krumholz; Amit X Garg; Chirag R Parikh
Journal:  JAMA       Date:  2006-09-20       Impact factor: 56.272

5.  "Renalism": inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency.

Authors:  Glenn M Chertow; Sharon-Lise T Normand; Barbara J McNeil
Journal:  J Am Soc Nephrol       Date:  2004-09       Impact factor: 10.121
  5 in total
  6 in total

Review 1.  Chronic kidney disease in the pathogenesis of acute ischemic stroke.

Authors:  Bharath Chelluboina; Raghu Vemuganti
Journal:  J Cereb Blood Flow Metab       Date:  2019-08-01       Impact factor: 6.200

2.  Cardiovascular outcome trials in patients with chronic kidney disease: challenges associated with selection of patients and endpoints.

Authors:  Patrick Rossignol; Rajiv Agarwal; Bernard Canaud; Alan Charney; Gilles Chatellier; Jonathan C Craig; William C Cushman; Ronald T Gansevoort; Bengt Fellström; Dahlia Garza; Nicolas Guzman; Frank A Holtkamp; Gerard M London; Ziad A Massy; Alexandre Mebazaa; Peter G M Mol; Marc A Pfeffer; Yves Rosenberg; Luis M Ruilope; Jonathan Seltzer; Amil M Shah; Salim Shah; Bhupinder Singh; Bergur V Stefánsson; Norman Stockbridge; Wendy Gattis Stough; Kristian Thygesen; Michael Walsh; Christoph Wanner; David G Warnock; Christopher S Wilcox; Janet Wittes; Bertram Pitt; Aliza Thompson; Faiez Zannad
Journal:  Eur Heart J       Date:  2019-03-14       Impact factor: 29.983

3.  Understanding and Overcoming the Challenges Related to Cardiovascular Trials Involving Patients with Kidney Disease.

Authors:  Julie H Ishida; Cynthia Chauhan; Barbara Gillespie; Ken Gruchalla; Peter A McCullough; Susan Quella; Alain Romero; Patrick Rossignol; David C Wheeler; Meaghan A Malley; Melissa West; Charles A Herzog
Journal:  Clin J Am Soc Nephrol       Date:  2021-04-23       Impact factor: 10.614

4.  Thromboembolic and Hemorrhagic Outcomes in the Direct Oral Anticoagulant Trials Across the Spectrum of Kidney Function.

Authors:  Nita A Limdi; Timothy Mark Beasley; Jielin Sun; Norman Stockbridge; Michael Pacanowski; Jeffry Florian
Journal:  Clin Pharmacol Ther       Date:  2021-01-19       Impact factor: 6.903

Review 5.  Diabetic kidney disease: new clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on "The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function".

Authors:  Giuseppe Pugliese; Giuseppe Penno; Andrea Natali; Federica Barutta; Salvatore Di Paolo; Gianpaolo Reboldi; Loreto Gesualdo; Luca De Nicola
Journal:  J Nephrol       Date:  2020-02       Impact factor: 3.902

6.  Temporal trends in treatment strategies and clinical outcomes among patients with advanced chronic kidney disease and ST-elevation myocardial infarctions: results from the Bremen STEMI registry.

Authors:  Johannes Schmucker; Andreas Fach; Rico Osteresch; Luis Alberto Mata Marin; Tina Retzlaff; Stephan Rühle; Daniela Garstka; Uwe Kuhlmann; Ingo Eitel; Rainer Hambrecht; Harm Wienbergen
Journal:  BMC Cardiovasc Disord       Date:  2022-04-01       Impact factor: 2.298
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.